Protocadherin-19 (PCDH19 or DEE9 or EFMR) Antibody - Western Blot Validated

Biological Background

Use this antibody to explore Protocadherin-19 in your model system. Protocadherin-19 is a contact-site protein that shapes barrier properties and signaling at the cell surface. Look for shifts in distribution that track with phenotype changes.

Tracking Protocadherin-19 can clarify whether changes reflect regulation, redistribution, or altered complex assembly.

Use in the Laboratory

Shifts in junction organization can accompany migration, tissue morphogenesis, and altered mechanical tension. Pair measurements with orthogonal readouts when interpretation is sensitive to context. Planar polarity studies may connect this target to directional signaling and cytoskeletal alignment.

Depending on the model, researchers may ask whether signal shifts reflect altered abundance, compartment changes, or remodeling of associated complexes.

To keep datasets interpretable, labs often document:

• subcellular redistribution at contact sites versus cytoplasm
• co-localization patterns with cytoskeletal elements
• changes in complex assembly with scaffold or adaptor proteins
• comparative profiling across cell states or perturbations

Version Notes

If your primary readout depends on denatured protein presentation, this option can streamline comparison across lanes and conditions. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so Protocadherin-19 patterns can be compared across experiments without guesswork.

With a clear focus on Protocadherin-19, this denaturing-format option fits streamlined studies and fast iteration.